Non-Hodgkin lymphoma - The Bloodline with Blood Cancer United Podcast

What happens when a resilience expert becomes the caregiver? When a loved one is diagnosed with blood cancer, you’re suddenly balancing fear, advocacy, and everyday life all at once. 

In this episode, we sit down with Karen Reivich, PhD, a resilience expert, caregiver, and wife of a lymphoma survivor. Karen opens up about the reality of supporting her husband through treatment and a clinical trial, sharing invaluable lessons on managing uncertainty, accepting help, and caring for yourself while caring for someone you love.

Mentioned on this episode: 

Additional Blood Cancer United Support Resources: 

The post Navigating Challenges as They Come: Resilience for Caregivers first appeared on The Bloodline with Blood Cancer United Podcast.

Two college students. Two lymphoma diagnoses. One unexpected love story.

In this episode, we speak with Kim and Josh Woda, who were both diagnosed with Hodgkin lymphoma while attending college. They share how they navigated school during treatment, coped with relapse and stem cell transplant, found support in the cancer community, and unexpectedly found each other. Their story is a powerful reminder that connection, understanding, and hope can appear when you least expect it.

Mentioned on this episode: 

Additional Blood Cancer United Support Resources: 

Episode supported by Kyowa Kirin Pharmaceutical Development Inc and Merck & Co.

The post Finding Each Other Along the Way: A Cancer Love Story first appeared on The Bloodline with Blood Cancer United Podcast.

Behind every policy is a patient, caregiver, or family whose story helped make change possible.

In this episode, we speak with Andrea Sanchez and Becki Chandler, volunteer advocates with Blood Cancer United, about the power of patient voices in shaping public policy. Drawing from their own family experiences with blood cancer, they discuss issues ranging from medical debt and insurance coverage to clinical trial access and research funding and explain how patients and caregivers can make their voices heard.

Learn why sharing your story matters and how personal experiences help lawmakers see that patients are more than numbers on a page. Behind every statistic is a real person, a unique story, and a family impacted by blood cancer.

Mentioned on this episode: 

Additional Blood Cancer United Support Resources: 

The post Making Your Voice Count: The Power of Patient Advocacy first appeared on The Bloodline with Blood Cancer United Podcast.

When you hear the word “aggressive,” it can feel overwhelming, but in diffuse large B-cell lymphoma (DLBCL), it can also point to something encouraging – a potential cure.

In this episode, we speak with Dr. Jonathon Cohen, of Winship Cancer Institute in Atlanta, GA, about what a DLBCL diagnosis really means, from how this common type of non-Hodgkin lymphoma is identified to current treatment options and emerging therapies. We explain what patients and families need to know about side effects. We also look at new treatments, including CAR T-cell therapy and bispecific antibodies, and the importance of open communication with your care team.

Mentioned on this episode: 

Additional Blood Cancer United Support Resources: 

Episode supported by Genmab US, Inc.

The post Diffuse Large B-Cell Lymphoma (DLBCL): Breaking Down an Aggressive Lymphoma first appeared on The Bloodline with Blood Cancer United Podcast.

Cutaneous T‑cell lymphoma (CTCL) is a rare condition that often raises important questions for patients and families.

In this episode, we sit down with Dr. Stefan Barta, of the University of Pennsylvania, to bring clarity to what CTCL is, how it’s diagnosed, and what patients can expect from staging and treatment. Dr. Barta breaks down the differences between CTCL subtypes, explains why diagnosing someone can take time, and shares the most up-to-date therapies, including skin directed treatments, immunotherapies, and emerging clinical trial options. Most importantly, he offers reassurance for those newly diagnosed: “The future is absolutely bright… there is a lot of hope for our patients with CTCL.”

Mentioned on this episode: 

Additional Blood Cancer United Support Resources: 

Episode supported by Kyowa Kirin, Inc. and Cutaneous Lymphoma Foundation.

The post Cutaneous T-Cell Lymphoma (CTCL): Illuminating a Brighter Path Forward first appeared on The Bloodline with Blood Cancer United Podcast.

In this episode, we sit down with Ann Grace MacMullan, Director of Integrative Wellness at the International Waldenstrӧm’s Macroglobulinemia Foundation (IWMF), to explore how wellness can become a powerful part of life after a cancer diagnosis. Ann Grace shares practical, calming techniques, including breathing exercises, “Bee’s Breath”, and guided meditation, that you can do anywhere to reduce stress and feel more grounded. We’ll also dive into what integrative wellness really means, why it matters for blood cancer patients, and how concepts like the “self-care sandwich” can help you start and end your day with intention.

Mentioned on this episode: 

Additional Blood Cancer United Support Resources: 

Episode supported by Merck & Co., Inc.

The post Hope Meets Healing: Simple Practices for Stress Relief first appeared on The Bloodline with Blood Cancer United Podcast.

Non-Hodgkin lymphoma (NHL) can sound overwhelming, but what does it really mean for patients and families? In this episode, we speak to Dr. Jean Koff of Winship Cancer Institute of Emory University, who breaks down the big picture of NHL: what it is, how it’s an umbrella term for multiple subtypes, and what today’s treatments and tomorrow’s innovations could mean for you. From understanding subtypes and staging to exploring options like watchful waiting, chemotherapy, and cutting-edge immunotherapies, we cover what matters most: knowledge, clarity, and hope.

Mentioned on this episode: 

Additional Blood Cancer United Support Resources: 

Supported by AbbVie Inc. and Genentech, A Member of the Roche Group.

The post The Big Picture on Non-Hodgkin Lymphoma: Treatments, Trends, and Tomorrow first appeared on The Bloodline with Blood Cancer United Podcast.

MRD (minimal/measurable residual disease) testing is changing the way doctors understand and monitor blood cancers.  In this episode, we talk with Dr. John Burke of the Rocky Mountain Cancer Center about how MRD testing works, what the results mean to patients and their care teams, and how ongoing clinical research is helping shape more personalized and hopeful approaches to treatment. 

Mentioned on this episode: 

Additional LLS Support Resources: 

Supported by Adaptive Biotechnologies Corporation and Allogene Therapeutics.

The post MRD Explained: What it Means for You and Your Care first appeared on The Bloodline with Blood Cancer United Podcast.

In this episode, we speak with Dianne Callahan, four-time cancer survivor, best-selling author, speaker, and patient advocate. Dianne shares her experiences with non-Hodgkin lymphoma and breast cancer, stem cell transplant, and survivorship while highlighting the importance of advocacy, joy, and intention in life after diagnosis. From her work with fundraising campaigns to legislative advocacy on Capitol Hill, Dianne offers inspiring insights on resilience, hope, and the power of living intentionally.

Mentioned on this episode: 

Additional LLS Support Resources: 

Supported by Genentech, A Member of the Roche Group.

The post Joy, Hope, and Healing Beyond a Cancer Diagnosis first appeared on The Bloodline with Blood Cancer United Podcast.

In this episode, we speak with Dianne Callahan, four-time cancer survivor, best-selling author, speaker, and patient advocate. Dianne shares her experiences with non-Hodgkin lymphoma and breast cancer, stem cell transplant, and survivorship while highlighting the importance of advocacy, joy, and intention in life after diagnosis. From her work with fundraising campaigns to legislative advocacy on Capitol Hill, Dianne offers inspiring insights on resilience, hope, and the power of living intentionally.

Mentioned on this episode: 

Additional LLS Support Resources: 

Supported by Genentech, A Member of the Roche Group.

The post Joy, Hope, and Healing Beyond a Cancer Diagnosis first appeared on The Bloodline with LLS.